Polycythaemia vera: Will new markers help us answer old questions?

Acta Haematologica

Volumn 108, Issue 3, 2002, Pages 120-131

  Pahl, Heike L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Erythrocytosis; Myeloproliferative disorders; Polycythaemia; Polycythaemia vera

Indexed keywords

MESSENGER RNA; PROTEIN PRV 1; RECEPTOR; SOMATOMEDIN; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

CELL CULTURE; CHROMOSOME 20Q; CHROMOSOME 9; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; DISEASE COURSE; DISEASE MARKER; ERYTHROID CELL; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HYPERSENSITIVITY; MEGAKARYOCYTE; PATHOPHYSIOLOGY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RNA ANALYSIS; STEM CELL;

BIOLOGICAL MARKERS; HUMANS; POLYCYTHEMIA VERA;

EID: 0036419910     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064709     Document Type: Review

References (71)

1. Prchal JF, Adamson JW, Steinmann L, Fialkow PJ: Human erythroid colony formation in vitro: Evidence for clonal origin. J Cell Physiol 1976;89:489-492.
2. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann BA: Polycythemia vera: Stem-cell and probable clonal origin of the disease. N Engl J Med 1976;295:913-916.
3. Mladenovic J, Adamson JW: Characteristics of circulating erythroid colony-forming cells in normal and polycythaemic man. Br J Haematol 1982;51:377-384.
4. Singer JW, Fialkow PJ, Adamson JW, Steinmann L, Ernst C, Murphy S, Kopecky KJ: Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine. J Clin Invest 1979;64:1320-1324.
5. Fauser AA, Messner HA: Pluripotent hemopoietic progenitors (CFU-GEMM) in polycythemia vera: Analysis of erythropoietin requirement and proliferative activity. Blood 1981;58:1224-1227.
6. Cashman JD, Eaves CJ, Eaves AC: Unregulated proliferation of primitive neoplastic progenitor cells in long-term polycythemia vera marrow cultures. J Clin Invest 1988;81:87-91.
7. Eaves AC, Henkelman DH, Eaves CJ: Abnormal erythropoiesis in the myeloproliferative disorders: An analysis of underlying cellular and humoral mechanisms. Exp Hematol 1980;8:235-247.
8. Prchal JF, Axelrad AA: Bone-marrow responses in polycythemia vera. N Engl J Med 1974;290:1382.
9. Adamson JW: Analysis of myeloproliferative disorders using cell markers in culture. Hämatol Bluttransfus 1979;23:205-210.
10. Adamson JW, Singer JW, Catalano P, Murphy S, Lin N, Steinmann L, Ernst C, Fialkow PJ: Polycythemia vera. Further in vitro studies of hematopoietic regulation. J Clin Invest 1980;66:1363-1368.
11. Lutton JD, Levere RD: Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera. Acta Haematol 1979;62:94-99.
12. Cashman J, Henkelman D, Humphries K, Eaves CJ, Eaves AC: Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny. Blood 1983;61:876-884.
13. Eaves CJ, Eaves AC: Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood 1978;52:1196-1210.
14. Shih LY, Lee CT, See LC, Ou YC, Dunn P, Wang PN, Kuo MC, Wu JH: In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia. Eur J Clin Invest 1998;28:569-576.
15. Lacombe C, Casadevall N, Varet B: Polycythaemia vera: In vitro studies of circulating erythroid progenitors. Br J Haematol 1980;44:189-199.
16. Fibach E, Rachmilewitz EA: Proliferation and differentiation of erythroid progenitors in liquid culture: Analysis of progenitors derived from patients with polycythemia vera. Am J Hematol 1990;35:151-156.
17. Silva M, Richard C, Benito A, Sanz C, Olalla I, Fernandez-Luna JL: Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. N Engl J Med 1998;338:564-571.
18. Roder S, Steimle C, Meinhardt G, Pahl HL: STAT3 is constitutively active in some patients with polycythemia rubra vera. Exp Hematol 2001;29:694-702.
19. Pahl HL: Towards a molecular understanding of polycythemia rubra vera. Eur J Biochem 2000;267:3395-3401.
20. Lemoine F, Najman A, Baillou C, Stachowiak J, Boffa G, Aegerter P, Douay L, Laporte JP, Gorin NC, Duhamel G: A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia. Blood 1986;68:996-1002.
21. Shih LY, Lee CT, Ou YC: Prediction of clinical course in patients with idiopathic erythrocytosis by endogenous erythroid colony assay but not by serum erythropoietin levels. Exp Hematol 1997;25:288-292.
22. Weinberg RS: In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders. Semin Hematol 1997;34:64-69.
23. Westwood NB, Pearson TC: Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Leuk Lymphoma 1996;22:95-103.
24. Biljanovic-Paunovic L, Ruvidic R, Pavlovic-Kentera V: Endogenous BFU-E in peripheral blood in diagnosis of polycythemia vera. Eur J Haematol 1990;45:262-266.
25. Beckman BS, Anderson WF, Beltran GS, Beckman EN, Fisher JW: Diagnostic use of CFU-E formation from peripheral blood in polycythemia vera. Am J Clin Pathol 1983;79:496-499.
26. Weinberg RS, Worsley A, Gilbert HS, Cuttner J, Berk PD, Alter BP: Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: Only polycythemia vera has endogenous colonies. Leuk Res 1989;13:331-338.
27. Masters GS, Baines P, Jacobs A: Erythroid colony growth from peripheral blood and bone marrow in polycythaemia. J Clin Pathol 1990;43:937-941.
28. Turhan AG, Cashman JD, Eaves CJ, Humphries RK, Eaves AC: Variable expression of features of normal and neoplastic stem cells in patients with thrombocytosis. Br J Haematol 1992;82:50-57.
29. Shih L-Y, Lee C-T: Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood 1994;83:744-748.
30. Florensa L, Besses C, Woessner S, Sole F, Acin P, Pedro C, Sans-Sabrafen J: Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia. Leukemia 1995;9:271-273.
31. Rolovic Z, Basara N, Gotic M, Sefer D, Bogdanovic A: The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis. Br J Haematol 1995;90:326-331.
32. Juvonen E, Ikkala E, Oksanen K, Ruutu T: Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: Diagnostic value and correlation to complications. Br J Haematol 1993;83:192-197.
33. Jantunen R, Juvonen E, Ikkala E, Oksanen K, Anttila P, Ruutu T: Development of erythrocytosis in the course of essential thrombocythemia. Ann Hematol 1999;78:219-222.
34. Partanen S, Ruutu T, Vuopio P: Circulating haematopoietic progenitors in myelofibrosis. Scand J Haematol 1982;29:325-330.
35. Smith BD, Moliterno AR: Biology and management of idiopathic myelofibrosis. Curr Opin Oncol 2001;13:91-94.
36. Moliterno AR, Siebel KE, Sun AY, Hankins WD, Spivak JL: A novel thrombopoietin signaling defect in polycythemia vera platelets. Stem Cells 1998;16:185-192.
37. Battegay EJ, Thomssen C, Nissen C, Gudat F, Speck B: Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders. Eur J Haematol 1989;42:321-326.
38. Croizat H, Amato D, McLeod DL, Eskinazi D, Axelrad AA: Differences among myeloproliferative disorders in the behavior of their restricted progenitor cells in culture. Blood 1983;62:578-584.
39. Taksin AL, Couedic JP, Dusanter-Fourt I, Masse A, Giraudier S, Katz A, Wendling F, Vainchenker W, Casadevall N, Debili N: Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L. Blood 1999;93:125-139.
40. Correa PN, Eskinazi D, Axelrad AA: Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: Studies in an improved serum-free medium. Blood 1994;83:99-112.
41. Kahn CR: Insulin resistance, insulin insensitivity, and insulin unresponsiveness: A necessary distinction. Metab Clin Exp 1978;27:1893-1902.
42. Dai C-H, Krantz SB, Means RT, Horn ST, Gilbert HS: Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. J Clin Invest 1991;87:391-396.
43. Dai CH, Krantz SB, Dessypris EN: Polycythemia vera II: Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin 3 and granulocyte-macrophage colony-stimulating factor. Blood 1992;80:891-899.
44. Mirza AM, Ezzat S, Axelrad AA: Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro. Blood 1997;89:1862-1869.
45. Mirza AM, Correa PN, Axelrad AA: Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor 1 receptor b subunit in circulating mononuclear cells of patients with polycythemia vera. Blood 1995;86: 877-882.
46. Axelrad AA, Eskinazi D, Correa PN, Amato D: Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia. Blood 2000;96:3310-3321.
47. Axelrad AA: Megakaryocytic hypersensitivity to thrombopoietin in essential thrombocythemia. Millennium Meeting on Myeloproliferative Diseases and Myelodysplastic Syndromes, New York, Oct 2000.
48. Kennedy EP, Hamilton SR: Genetics of colorectal cancer. Semin Surg Oncol 1998;15:126-130.
49. Ilyas M, Straub J, Tomlinson IP, Bodmer WF: Genetic pathways in colorectal and other cancers. Eur J Cancer 1999;35:335-351.
50. Rege-Cambrin G, Mecucci C, Tricot G, Michaux JL, Louwagie A, Van Hove W, Francart H, Van den Berghe H: A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet 1987;25:233-245.
51. Hinshelwood S, Bench AJ, Green AR: Pathogenesis of polycythaemia vera. Blood Rev 1997;11:224-232.
52. Bench AJ, Aldred MA, Humphray SJ, Champion KM, Gilbert JG, Asimakopoulos FA, Deloukas P, Gwilliam R, Bentley DR, Green AR: A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region. Genomics 1998;49:351-362.
53. Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, Swanton S, Champion KM, Li J, Whittaker P, Stavrides G, Hunt AR, Huntly BJ, Campbell LJ, Bentley DR, Deloukas P, Green AR: Chromosome 20 deletions in myeloid malignancies: Reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene 2000;19:3902-3913.
54. Kralovics R, Stockton DW, Prchal JT: Genome-wide search for the genetic defect in polycythemia vera. Blood 2000;96:741a.
55. Kralovics R, Guan YL, Prchal JT: Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol 2002;30:229-236.
56. Moliterno AR, Hankins D, Spivak JL: Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 1998;338:572-580.
57. Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y: Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 1997;90:4031-4038.
58. Harrison CN, Gale RE, Pezella F, Mire-Sluis A, Machin SJ, Linch DC: Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. Br J Haematol 1999;107:139-147.
59. Moliterno AR, Spivak JL: Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood 1999;94:2555-2561.
60. Moliterno AR, Williams DM, Spivak JL: Enhanced in vitro viability of polycythemia vera CD34+ cells is associated with abnormal thrombopoietin receptor expression and aberrant signal transduction. Blood 2001;98:469a.
61. Moliterno AR, Silver RT, Spivak JL: A diagnostic assay for polycythemia vera. Blood 2000;96:512a.
62. Le Blanc K, Andersson P, Samuelsson J: Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera. Br J Haematol 2000;108:80-85.
63. Temerinac S, Klippel S, Strunck E, Röder S, Lübbert M, Lange W, Azemar M, Meinhardt G, Schaefer HE, Pahl HL: Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood 2000;95:2569-2576.
64. Kissel K, Santoso S, Hofmann C, Stroncek D, Bux J: Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions. Eur J Immunol 2001;31:1301-1309.
65. Klippel S, Strunck E, Temerinac S, Kralovics R, Prchal JT, Griesshammer M, Heimpel H, Pahl HL: Quantification of PRV-1 expression, a molecular marker for the diagnosis of polycythemia vera. Blood 2001;98:470a.
66. Klippel S, Strunck E, Busse CE, Behringer D, Pahl HL: Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood, in press.
67. Ronne E, Pappot H, Grondahl-Hansen J, Hoyer-Hansen G, Plesner T, Hansen NE, Dano K: The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1995;89:576-581.
68. Strunck E, Bliestle H, Temerinac S, Pahl HL: Characterization of the promoter for PRV-1, a gene overexpressed in polycythemia vera. Blood 2000;96:511a.
69. Dameshek W: Some speculations on the myelo-proliferative syndromes. Blood 1951;6:372-375.
70. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P, Dohner H: Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 1994;83:1922-1928.
71. The German MPD Initiative. First Falkau Conference, June 2001.